Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice

被引：0
|
作者：
Sha Sha
Xiaoming Liu
Ruxing Zhao
Li Qing
Qin He
Lei Sun
Li Chen
机构：
[1] Qilu Hospital of Shandong University,Department of Endocrinology
[2] Institute of Endocrine and Metabolic Diseases of Shandong University,Key Laboratory of Endocrine and Metabolic Diseases
[3] Shandong Province medicine& health,undefined
来源：
Endocrine | 2019年 / 66卷
关键词：
Obesity; Immune; GLP-1; Metabolic syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：494 / 502
页数：8
相关论文
共 50 条
  • [1] Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice
    Sha, Sha
    Liu, Xiaoming
    Zhao, Ruxing
    Qing, Li
    He, Qin
    Sun, Lei
    Chen, Li
    ENDOCRINE, 2019, 66 (03) : 494 - 502
  • [2] Protective Effects of Glucagon-Like Peptide-1 Analog on Renal Tubular Injury in Mice on High-Fat Diet
    Gun, Honglei
    Li, Hongmei
    Wang, Bin
    Ding, Wei
    Ling, Lilu
    Yang, Min
    Niu, Jianying
    Gu, Yong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (03) : 1113 - 1124
  • [3] Pharmacokinetics and pharmacodynamics of the glucagon-like peptide-1 analog liraglutide in healthy cats
    Hall, M. J.
    Adin, C. A.
    Borin-Crivellenti, S.
    Rudinsky, A. J.
    Rajala-Schultz, P.
    Lakritz, J.
    Gilor, C.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2015, 51 : 114 - 121
  • [4] Glucagon-Like Peptide-1 Receptor Knockout Mice Are Protected from High-Fat Diet-Induced Insulin Resistance
    Ayala, Julio E.
    Bracy, Deanna P.
    James, Freyja D.
    Burmeister, Melissa A.
    Wasserman, David H.
    Drucker, Daniel J.
    ENDOCRINOLOGY, 2010, 151 (10) : 4678 - 4687
  • [5] Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice
    Franklin, Zara J.
    Lafferty, Ryan A.
    Flatt, Peter R.
    McShane, Laura M.
    O'Harte, Finbarr P. M.
    Irwin, Nigel
    BIOCHIMIE, 2022, 199 : 60 - 67
  • [6] Glucagon-like peptide-1 analog, liraglutide, regulates Sertoli cell energy metabolism
    Dasso, Marina Ercilia
    Centola, Cecilia Lucia
    Galardo, Maria Noel
    Meroni, Silvina Beatriz
    Riera, Maria Fernanda
    JOURNAL OF ENDOCRINOLOGY, 2024, 263 (03)
  • [7] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [8] A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
    Tashiro, Yuko
    Sato, Kengo
    Watanabe, Takuya
    Nohtomi, Kyoko
    Terasaki, Michishige
    Nagashima, Masaharu
    Hirano, Tsutomu
    PEPTIDES, 2014, 54 : 19 - 26
  • [9] Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity
    Knudsen, Lotte Bjerre
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2019, 2 (06) : 468 - 484
  • [10] Pharmacokinetics and Pharmacodynamics of Liraglutide, a Long-Acting, Potent Glucagon-Like Peptide-1 Analog
    Meece, Jerry
    PHARMACOTHERAPY, 2009, 29 (12): : 33S - 42S
12345